Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Israel-Hamas war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    Most Read
    • Israel and Hamas resume fighting after ceasefire expires
    • Israel plans for ‘long war’ and aims to kill top three Hamas leaders
    • Traders boost US rate cut bets despite pushback from Fed’s Jay Powell
    • Venezuela to hold referendum on seizing part of Guyana — and its oil
    • UAE COP28 guest list led by bankers, lobbyists — and housekeeping
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • US moves to choke China’s role in electric vehicle supply chain
      • Signa sold prized KaDeWe property at cut price
      • James Dyson loses libel case against Daily Mirror
      • Reclusive Shein founder Sky Xu prepares to enter the spotlight with IPO
      • Thames Water owners pile group with debt
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Wealth Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • News updates from December 1: S&P 500 closes at 20-month high and gold hits record despite rate cut pushback from Powell, Israel resumes fighting against Hamas
      • Venezuela to hold referendum on seizing part of Guyana — and its oil
      • HMRC urges crypto holders to disclose gains
      • Brookfield raises $28bn for largest-ever infrastructure fund
      • Charlie Munger and the Magnificent Seven
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
      Most Read
      • Should we believe Americans when they say the economy is bad?
      • Charlie Munger and the Magnificent Seven
      • Nvidia played its way to the domination of AI
      • The only way out of the Gaza impasse requires global effort
      • Should businesses have to share profits with employees?
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      • Working It
      Most Read
      • Why companies are tapping the boardroom for their next CEO
      • Desks by the hour: why flexible offices are a hit with business
      • ‘Double dipping’: why managers worry that staff have a second job on the sly
      • The people defending humanity from AI can’t even write a decent press release
      • Should I switch non-profit work for the corporate world?
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • The FT’s 25 most influential women of 2023
      • Celebrity lawyer David Sherborne: ‘I regard myself as on the side of the angels’
      • Pete Townshend: ‘The Who were a very difficult band to create music for’
      • How to design a home for entertaining
      • Switzerland’s wildest ski tour
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Antibiotic resistance

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Monday, 2 October, 2023
      Special ReportFT Health: Future of Antibiotics
      Ukraine infections show rising threat from antibiotic resistance

      Economic and political fallout from war distracts governments from health threats

      A paramedic measures the blood pressure of a wounded soldier at a mobile clinic
    • Thursday, 14 September, 2023
      Special Report
      FT Health: Communicable Diseases

      Climate change helps the spread of infectious diseases. Plus: rise in fungal infections highlights risks of antimicrobial resistance; Sydney shows how to almost eliminate HIV transmission; wait goes on for effective Long Covid treatments

      a tiger mosquito on a person’s skin
    • Thursday, 14 September, 2023
      Special ReportFT Health: Communicable Diseases
      Rise in fungal infections illustrates risks of antimicrobial resistance

      Drug resistance is not just a problem with bacteria

      A microscopic image of a yeast that causes infections
    • Tuesday, 29 August, 2023
      Drugs research
      Non-profit and industry investors propose paediatric cancer fund

      New model aims to reduce high development costs and increase number of drugs being tested

      An oncological day clinic in Munich
    • Monday, 28 August, 2023
      Disease control and prevention
      Japanese drugmaker urges G7 to fix infectious diseases market

      Shionogi chief warns companies are deserting the field to focus on more lucrative areas

    • Monday, 28 August, 2023
      The Big Read
      Superbugs: why it’s so hard to stop the ‘silent pandemic’

      Antimicrobial resistance already kills millions and is projected to get worse. But there is little incentive for Big Pharma to tackle the issue

      FT montage of bacteria and pill capsules
    • Wednesday, 23 August, 2023
      Anjana Ahuja
      New bacterial ‘dark matter’ offers hope for a drug-resistant world

      As the antibiotic pipeline empties, a fresh approach to studying bacteria has emerged

      Illustration of a scientist opening a pill capsule to unleash a new antibiotic to kill bacteria
    • Tuesday, 22 August, 2023
      Investor activism
      Food companies face investor calls to curb antibiotic use on farms

      Awareness about the negative impact of antimicrobial resistance on shareholder returns is growing

      Chickens gathered to drink water on a farm
    • Wednesday, 16 August, 2023
      UK moves to combat antimicrobial resistance with overseas investment

      Health department to spend £210mn to track deadly superbugs across Asia and Africa

      A multi-drug resistant bacteria
    • Monday, 7 August, 2023
      Antibiotic resistance linked to air pollution, study suggests

      Research finds superbugs increase in tandem with levels of small particulate matter in the air

      Traffic passing through thick greyish smoke
    • Monday, 3 July, 2023
      National Health Service
      NHS plans wider rollout of UK subscription model for antibiotics

      Successful pilot in England will be expanded to more pharma companies and include N Ireland, Scotland and Wales

      Boxes of tablets on a shelf
    • Wednesday, 24 May, 2023
      The FT ViewThe editorial board
      Investors can play their part in the war on superbugs

      As McDonald’s is targeted, governments also need to tighten and enforce rules

      Cows in a field in County Donegal, Ireland
    • Wednesday, 24 May, 2023
      Special ReportFT Health: Future of Antibiotics
      Pollution from antibiotic factories highlighted as public health risk

      Governments and some pharma companies try to tackle problem linked with drug resistance

      a public hot water pool along the Parvati river and, on the other side, the Gurudwara Shri Sahib
    • Sunday, 21 May, 2023
      McDonald's Corp
      European asset managers take on McDonald’s over antibiotics

      Legal & General and Amundi say antimicrobial resistance poses a wider economic threat

    • Wednesday, 17 May, 2023
      Moral Money
      Rising tide for $1bn water start-up Premium content

      Also in today’s newsletter, investors look to the next health crisis on the horizon

      Shallow water topped with white foam
    • Monday, 20 February, 2023
      Special ReportImpact Investing
      Impact funds help fight dementia and antibiotic resistance

      Some of the world’s biggest health challenges do not lend themselves to conventional investment

      Gloved hands hold a Petri dish speckled with bacteria
    • Wednesday, 8 February, 2023
      Special ReportFT Health: Future of Antibiotics
      Spread of antibiotic resistance revives interest in bacteria-killing viruses

      Experts believe bacteriophages could be crucial extra tool

      An electron microscope shows bacteriophages attacking an E.coli bacterium
    • Wednesday, 21 December, 2022
      Explainer
      Surge in infections leads to global shortage of antibiotics

      Manufacturers struggle to keep pace with post-pandemic demand as dozens of countries report low supply of drugs

      A petri dish with a cultured superbug, the globe and an amoxicillin capsule
    • Monday, 21 November, 2022
      Special ReportFT Health: Future of Antibiotics
      Tighter controls on antibiotics promise to curb drug-resistance

      Medicines are often given for viral infections such as flu, for which they are useless, but can cause side effects

      A customer handing a prescription from his doctor to his local pharmacist.
    • Friday, 11 November, 2022
      Special ReportFT Health: Future of Antibiotics
      Pandemic holds back fight against antibiotic resistance

      Few countries have well funded plans to tackle health threat to millions

      pharmacist prepares a diluted solution of phages from three different concentrated types of phages
    • Thursday, 27 October, 2022
      Special ReportFT Health: Future of Antibiotics
      Drugmakers eye government money to combat antibiotic resistance

      Industry cautiously optimistic amid bipartisan support for US Pasteur bill

    • Wednesday, 7 September, 2022
      How ‘Fitbits for cows’ can tackle the antibiotic crisis

      Monitoring the health of cattle lowers the use of drugs — and the risk of bacterial resistance to them

    • Tuesday, 19 July, 2022
      Special ReportFT Health: Future of Antibiotics
      Antibiotic resistance raises prospect of untreatable gonorrhoea

      Just one drug remains effective for the sexually transmitted disease but soon the bacteria may be able to evade it

      Ceftriaxone against the background of a colorised scanning electron micrograph of Neisseria gonorrhoeae bacteria, which causes gonorrhea.
    • Tuesday, 19 July, 2022
      Special ReportFT Health: Future of Antibiotics
      India’s shrimp farms test antibiotic control

      Fast-growing food sector has become a test case for the use and abuse of the drugs

      Hands holding freshly harvested shrimp
    • Tuesday, 19 July, 2022
      Special ReportFT Health: Future of Antibiotics
      Drug-resilient bacteria threat rises with spread of world’s war zones

      Infected wounds are growing cause for concern in the Middle East, Ukraine and beyond

      Ambulance workers bringing in a patient to a hospital
    Previous page You are on page 1 Next page

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookie PolicyManage CookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

    Tools

    PortfolioToday’s Newspaper (FT Digital Edition)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Israel-Hamas war
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
      • Artificial intelligence
      • Semiconductors
      • Cyber Security
      • Social Media
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Wealth Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      • Working It
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • Visual and data journalism
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today’s Newspaper (FT Digital Edition)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In